You have been redirected to your local version of the requested page

AN-NIR-017

NIR "predictive model" for the release of pharmaceutical active ingredients from solid dosage forms


Summary

This Application Note shows that NIR "predictive models" are optimally suitable for the non-destructive measurement of the release profiles of active ingredients from tablets. This is in accordance with the Process Analytical Technology (PAT) initiative of the FDA. The results demonstrate how NIRS considerably reduces the work involved for release studies in the laboratory.

Contact

Metrohm USA

9250 Camden Field Pkwy
33578 Riverview, FL

Contact

Find Applications
Refine your search

This application has been tagged under

// Tablets, capsules, pharmaceutical powders